← Back to Search

Other

Hyperbaric Oxygen for Traumatic Brain Injury (HYBOBI2 Trial)

Phase 2
Waitlist Available
Led By Lindell K. Weaver, MD
Research Sponsored by Lindell Weaver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

HYBOBI2 Trial Summary

This study is evaluating whether hyperbaric oxygen therapy might improve long-term symptoms after brain injury.

Eligible Conditions
  • Traumatic Brain Injury

HYBOBI2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Incidence of myopia
Neurobehavioral Symptom Inventory

HYBOBI2 Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Hyperbaric OxygenExperimental Treatment1 Intervention
100% oxygen at 1.5 atmospheres absolute for 60 minutes, 40 sessions
Group II: Minimal pressure airPlacebo Group1 Intervention
Regular air at minimal pressurization for 60 minutes, 40 sessions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric Oxygen
2005
Completed Phase 3
~260

Find a Location

Who is running the clinical trial?

Lindell WeaverLead Sponsor
1 Previous Clinical Trials
83 Total Patients Enrolled
Lindell K. Weaver, MDPrincipal InvestigatorIntermountain Health Care, Inc.
3 Previous Clinical Trials
405 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025